ClinicalTrials.gg
Drug

KH902 fusion protein clinical trials

Also written Conbercept and KH902.

studies test it
21
open now
1
in phase 3
2
first study started
2010

How each study uses KH902 fusion protein is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the KH902 fusion protein studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

KH902
2

Other names

Conbercept
15

Studies by the year they started

21 studies that test it; most in 2016 (3)

Studies that test KH902 fusion protein, by start year
YearStudies
20101
20111
20122
20142
20151
20163
20171
20181
20191
20202
20212
20221
20243

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
1
Phase 2
9
Phase 3
2
Phase 4
3
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 12

Chengdu Kanghong Biotech Co., Ltd. (8) · Ruijin Hospital (2) · Sun Yat-sen University (2) · Shanghai Eye Disease Prevention and Treatment Center (1) · Bojie Hu (1) · RemeGen Co., Ltd. (1) · Tianjin Medical University Eye Hospital (1) · Wang Yusheng (1)

Often tested with

Tested in the same studies.

Faricimab (1) · Paclitaxel (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test KH902 fusion protein.

Studies

Open first, then newest update. How each study uses KH902 fusion protein is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 21

See all 21 studies that test KH902 fusion protein →

Given beside what is tested · 2 — KH902 fusion protein is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with KH902 fusion protein

Codes

What other systems call KH902 fusion protein · ClinicalTrials.gg INT005241

  • MeSH (NLM) C527363KH902 fusion proteinOne source NLM
  • UNII (FDA) 1P05PW62F3CONBERCEPTConfirmed FDA, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.